mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.06 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |